Pfizer Inc (PFE) is destined for greater heights as its last quarter sales were 17,702 M

On Friday, Pfizer Inc (NYSE: PFE) was 1.47% up from the session before settling in for the closing price of $25.83. A 52-week range for PFE has been $24.48 – $31.54.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 10.96%. When this article was written, the company’s average yearly earnings per share was at 58.10%. With a float of $5.66 billion, this company’s outstanding shares have now reached $5.67 billion.

The extent of productivity of a business whose workforce counts for 88000 workers is very important to gauge. In terms of profitability, gross margin is 59.1%, operating margin of 16.85%, and the pretax margin is 6.49%.

Pfizer Inc (PFE) Insider Updates

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Pfizer Inc stocks. The insider ownership of Pfizer Inc is 0.04%, while institutional ownership is 67.54%. The most recent insider transaction that took place on Oct 30 ’24, was worth 28,240. In this transaction Director of this company bought 1,000 shares at a rate of $28.24, taking the stock ownership to the 10,000 shares. Before that another transaction happened on Aug 13 ’24, when Company’s SVP & Controller sold 5,154 for $28.66, making the entire transaction worth $147,714. This insider now owns 8,582 shares in total.

Pfizer Inc (PFE) Performance Highlights and Predictions

According to the Wall Street analysts, stocks earnings will be around 58.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.10% during the next five years compared to -27.43% drop over the previous five years of trading.

Pfizer Inc (NYSE: PFE) Trading Performance Indicators

You can see what Pfizer Inc (PFE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.51. Likewise, its price to free cash flow for the trailing twelve months is 18.32.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.74, a number that is poised to hit 0.48 in the next quarter and is forecasted to reach 2.89 in one year’s time.

Technical Analysis of Pfizer Inc (PFE)

The latest stats from [Pfizer Inc, PFE] show that its last 5-days average volume of 36.57 million was inferior to 38.43 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 74.67%. Additionally, its Average True Range was 0.59.

During the past 100 days, Pfizer Inc’s (PFE) raw stochastic average was set at 24.50%, which indicates a significant decrease from 73.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.56% in the past 14 days, which was higher than the 21.84% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $27.90, while its 200-day Moving Average is $28.07. Now, the first resistance to watch is $26.37. This is followed by the second major resistance level at $26.53. The third major resistance level sits at $26.83. If the price goes on to break the first support level at $25.91, it is likely to go to the next support level at $25.61. Assuming the price breaks the second support level, the third support level stands at $25.45.

Pfizer Inc (NYSE: PFE) Key Stats

There are 5,666,990K outstanding shares of the company, which has a market capitalization of 150.72 billion. As of now, sales total 58,496 M while income totals 2,119 M. Its latest quarter income was 17,702 M while its last quarter net income were 4,465 M.